IL318765A - Predicting response to il-6 antagonists - Google Patents

Predicting response to il-6 antagonists

Info

Publication number
IL318765A
IL318765A IL318765A IL31876525A IL318765A IL 318765 A IL318765 A IL 318765A IL 318765 A IL318765 A IL 318765A IL 31876525 A IL31876525 A IL 31876525A IL 318765 A IL318765 A IL 318765A
Authority
IL
Israel
Prior art keywords
antagonists
predicting response
predicting
response
Prior art date
Application number
IL318765A
Other languages
Hebrew (he)
Inventor
Marina Mesquida
Everson Nogoceke
Original Assignee
Hoffmann La Roche
Marina Mesquida
Everson Nogoceke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche, Marina Mesquida, Everson Nogoceke filed Critical Hoffmann La Roche
Publication of IL318765A publication Critical patent/IL318765A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/248—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL318765A 2022-10-24 2023-10-23 Predicting response to il-6 antagonists IL318765A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP22203165 2022-10-24
PCT/EP2023/079391 WO2024088921A1 (en) 2022-10-24 2023-10-23 Predicting response to il-6 antagonists

Publications (1)

Publication Number Publication Date
IL318765A true IL318765A (en) 2025-04-01

Family

ID=83995003

Family Applications (1)

Application Number Title Priority Date Filing Date
IL318765A IL318765A (en) 2022-10-24 2023-10-23 Predicting response to il-6 antagonists

Country Status (11)

Country Link
US (1) US20250333495A1 (en)
EP (1) EP4608861A1 (en)
JP (1) JP2025535355A (en)
KR (1) KR20250093319A (en)
CN (1) CN120112551A (en)
AU (1) AU2023369998A1 (en)
CA (1) CA3264497A1 (en)
IL (1) IL318765A (en)
MX (1) MX2025004613A (en)
TW (1) TW202426494A (en)
WO (1) WO2024088921A1 (en)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69233528T2 (en) 1991-11-25 2006-03-16 Enzon, Inc. Process for the preparation of multivalent antigen-binding proteins
ATE199392T1 (en) 1992-12-04 2001-03-15 Medical Res Council MULTIVALENT AND MULTI-SPECIFIC BINDING PROTEINS, THEIR PRODUCTION AND USE
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
EP0979281B1 (en) 1997-05-02 2005-07-20 Genentech, Inc. A method for making multispecific antibodies having heteromultimeric and common components
JP3614866B2 (en) 1997-06-12 2005-01-26 リサーチ コーポレイション テクノロジーズ,インコーポレイティド Artificial antibody polypeptide
DE69941267D1 (en) 1998-12-10 2009-09-24 Bristol Myers Squibb Co PROTEIN EQUIPMENT FOR ANTIBODY-NACHHAMMER AND OTHER BINDING PROTEINS
JP4369662B2 (en) 2001-04-26 2009-11-25 アビディア インコーポレイテッド Combinatorial library of monomer domains
US20030157561A1 (en) 2001-11-19 2003-08-21 Kolkman Joost A. Combinatorial libraries of monomer domains
WO2006028936A2 (en) 2004-09-02 2006-03-16 Genentech, Inc. Heteromultimeric molecules
KR102149206B1 (en) 2012-11-08 2020-08-31 세센 바이오, 아이엔씨. Il-6 antagonists and uses thereof
SI3215530T1 (en) * 2014-11-07 2020-02-28 Sesen Bio, Inc. Enhanced IL-6 antibodies
WO2016089886A2 (en) * 2014-12-02 2016-06-09 Regeneron Pharmaceuticals, Inc. Methods for treating dry eye disease by administering an il-6r antagonist
BR112018008900A8 (en) * 2015-11-03 2019-02-26 Regeneron Pharma compositions comprising IL6R antibodies for the treatment of uveitis and macular edema and methods of use thereof
WO2021226404A1 (en) * 2020-05-08 2021-11-11 Kodiak Sciences Inc. Use of il-6 antibodies and vegf traps, and fusion constructs and conjugates thereof

Also Published As

Publication number Publication date
US20250333495A1 (en) 2025-10-30
KR20250093319A (en) 2025-06-24
WO2024088921A1 (en) 2024-05-02
TW202426494A (en) 2024-07-01
JP2025535355A (en) 2025-10-24
CA3264497A1 (en) 2024-05-02
AU2023369998A1 (en) 2025-01-23
MX2025004613A (en) 2025-06-02
EP4608861A1 (en) 2025-09-03
CN120112551A (en) 2025-06-06

Similar Documents

Publication Publication Date Title
EP4420617C0 (en) COMPRESSABLE NON-FIBERY ADDITIVES
EP3776283A4 (en) DIGITAL CONSTRUCTION TOOLS FOR BUILDING CONSTRUCTION
EP3926100A4 (en) UNDERWATER CONCRETE BLOCK STRUCTURE CONSTRUCTION METHOD
EP4073075A4 (en) SSTR5 ANTAGONISTS
IL285246A (en) Substitute bicyclic compounds as modular farnesoid x receptors
EP4067506A4 (en) BIOMARKER FOR PREDICTING THERAPEUTIC RESPONSIVENESS TO A THERAPEUTIC AGENT OF IMMUNE CELLS
ZA202007980B (en) P2x3 receptor antagonists
GB202019622D0 (en) Antagonist compounds
IL292639A (en) Heterocyclic nmda antagonist
EP4511368A4 (en) CCR4 ANTAGONISTS
EP4006033A4 (en) ADENOSINE RECEPTOR ANTAGONIST
EP4257765A4 (en) OCTAHEDRAL RETICULATED STEREO MODULE FOR BUILDING CONSTRUCTION
HUE058848T2 (en) Inflammatory biomarkers for predicting responsiveness to FGF-18 compound
GB2607218B (en) Sound-insulating structure for building
EP4452969A4 (en) PIPERAZINE-INDAZOLE-GLUCOCORTICOID RECEPTOR ANTAGONISTS
EP3798588C0 (en) MONOLITHIC WEIGHING BLOCK
IL291502A (en) Agonist of tacr2
PL4041388T3 (en) PROSTAGLANDIN EP4 RECEPTOR ANTAGONIST COMPOUNDS
EP3924556C0 (en) MONOLITHIC NETWORK STRUCTURE FOR GEO-GRIDS
IL285557A (en) Resistant compounds used are similar to farnesoid x receptor antagonists
IL290024A (en) Bicyclic cx3cr1 receptor agonists
EP3983416C0 (en) CGRP antagonist compounds
EP3983417C0 (en) CGRP antagonist compounds
EP3889133A4 (en) STROGEN RECEPTOR ANTAGONIST
PT3647499T (en) Concrete structure